GoHealth, Inc. (NASDAQ:GOCO) Q4 2023 Earnings Conference Call March 14, 2024 8:00 AM ET Company Participants John Shave - Vice President of Investor Relations Vijay Kotte - Chief Executive Officer Jason Schulz - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Patrick McCann - Noble Capital Market Jim Sidoti - Sidoti & Company Sandeep Soorya - Delaware Street Capital Operator Good morning. Welcome to GoHealth's Fourth Quarter and Full Year 2023 Earnings Call. My name is ...

FORWARD-LOOKING STATEMENTS These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this Presentation may be forward-looking statements. Statements regarding the Company's future results of operations and financial position, business strategy and plans and objectives of management for future operations, including, among others, statements regarding expected financial perfo ...

"As we reflect on our achievements this past year, our consumer-centric focus shifted from enrollment to engagement, with trust at its core. Our innovative PlanFit CheckUp program is a prime example of our commitment to the consumer and a driver of our 2023 results. By prioritizing the real needs of Medicare consumers, we continue to enhance consumer trust and set a new standard for industry practices, said Vijay Kotte, CEO of GoHealth. "Our approach underscores our mission to transform the consumer healthc ...

For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware 85-0563805 (St ...

Additional non-GAAP financial measures, including net revenue excluding the Lookback Adjustments, Adjusted EBITDA excluding the Lookback Adjustments, net revenue excluding both the Non-Encompass BPO services revenue and the Lookback Adjustments and Adjusted EBITDA excluding both the Non-Encompass BPO services gross margin and the Lookback Adjustments, are also included in this Press Release. The Lookback Adjustments are revenue adjustments that represent changes in estimates relating to performance obligati ...

GoHealth, Inc. (NASDAQ:GOCO) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants John Shave – Vice President of Investor Relations Vijay Kotte – Chief Executive Officer Jason Schulz – Chief Financial Officer Conference Call Participants Sandeep Soorya – Delaware Street Capital Jim Sidoti – Sidoti & Company Greg Aurand – Noble Capital Sandeep Soorya – Delaware Street Capital Operator Good morning, and welcome to the GoHealth Third Quarter 2023 Earnings Conference Call. My name i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 214 West Huron St. Chicago, Illinois 60654 (Address of principal executive offices) (Zip Code) (312) 386-8200 (Registrant's telephone number, including area code) For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro ...

GoHealth, Inc. (NASDAQ:GOCO) Q2 2023 Earnings Conference Call August 10, 2023 8:00 AM ET Company Participants John Shave - VP, IR Vijay Kotte - CEO Jason Schulz - CFO Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day and thank you for standing by. Welcome to the GoHealth Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. P ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware 85-0563805 (State ...

GoHealth, Inc. (NASDAQ:GOCO) Q1 2023 Earnings Conference Call May 8, 2023 8:00 AM ET Company Participants John Shave - VP of IR Vijay Kotte - CEO Jason Schulz - CFO Conference Call Participants Mike Cherny - Bank of America Jonathan Yong - Credit Suisse Ben Hendrix - RBC Capital Markets Operator Good morning, and welcome to the GoHealth First Quarter 2023 Earnings Conference Call. My name is Michelle, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Fol ...